BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2913611)

  • 1. Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
    Stram DO; Mizuno S
    Radiat Res; 1989 Jan; 117(1):93-113. PubMed ID: 2913611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation.
    Otake M; Neriishi K; Schull WJ
    Radiat Res; 1996 Sep; 146(3):339-48. PubMed ID: 8752314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An estimate of the magnitude of random errors in the DS86 dosimetry from data on chromosome aberrations and severe epilation.
    Sposto R; Stram DO; Awa AA
    Radiat Res; 1991 Nov; 128(2):157-69. PubMed ID: 1947012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
    Gilbert ES; Ohara JL
    Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
    Preston DL; Pierce DA
    Radiat Res; 1988 Jun; 114(3):437-66. PubMed ID: 3375435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between cataracts and epilation in atomic bomb survivors.
    Neriishi K; Wong FL; Nakashima E; Otake M; Kodama K; Choshi K
    Radiat Res; 1995 Oct; 144(1):107-13. PubMed ID: 7568764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.
    Sasaki MS; Nomura T; Ejima Y; Utsumi H; Endo S; Saito I; Itoh T; Hoshi M
    Radiat Res; 2008 Jul; 170(1):101-17. PubMed ID: 18582156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effectiveness of neutrons from Hiroshima bomb replica: results of a collaborative cytogenetic study.
    Dobson RL; Straume T; Carrano AV; Minkler JL; Deaven LL; Littlefield LG; Awa AA
    Radiat Res; 1991 Nov; 128(2):143-9. PubMed ID: 1947011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors.
    Neriishi K; Stram DO; Vaeth M; Mizuno S; Akiba S
    Radiat Res; 1991 Feb; 125(2):206-13. PubMed ID: 1996379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable chromosome aberrations among A-bomb survivors: an update.
    Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
    Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.
    Kellerer AM; Rühm W; Walsh L
    Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M; Schull WJ
    Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.